NCT04736836View on ClinicalTrials.gov

Microbial Resistance of Rifaximin in Hepatic Encephalopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

June 30, 2019

Conditions
Hepatic Encephalopathy
Interventions
DRUG

Rifaximin

locally absorbed antibiotic

All Listed Sponsors
lead

National Hepatology & Tropical Medicine Research Institute

OTHER_GOV

NCT04736836 - Microbial Resistance of Rifaximin in Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter